Prostate Cancer - Results from #26080

The results of real-time brachytherapy for the management of low- and intermediate-risk prostate cancer in patients with prostate volumes up to 100 mL - Abstract April 3, 2012

Dietary factors and epigenetic regulation for prostate cancer prevention - Abstract April 3, 2012

Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: An institutional report - Abstract April 3, 2012

Compassionate use of abiraterone and cabazitaxel : First experiences in docetaxel-pretreated castration-resistant prostate cancer patients - Abstract April 3, 2012

Molecular markers as predictive factors biochemical failure after radical treatment of prostate cancer - Abstract April 3, 2012

Quality of life after biochemical recurrence in patients with prostate cancer. How and how long do patients live after biochemical recurrence? - Abstract April 3, 2012

Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells - Abstract April 3, 2012

The clinical merit of anti-RANKL antibody denosumab in prostate cancer - Abstract April 3, 2012

Early clinical data show galeterone safe, effective against prostate cancer April 2, 2012

Metformin appeared to slow prostate cancer growth April 2, 2012

Oral vitamin D supplements reduced levels of Ki67 in prostate cancer cells April 2, 2012

Lack of oxygen influenced tumor behavior and patient outcome in intermediate-risk prostate cancer April 2, 2012

Novel technology allows for noninvasive imaging of prostate cancer April 2, 2012

Weill Cornell investigators among several centers chosen for "dream team" awarded $10 million to study metastatic prostate cancer April 2, 2012

Prostate Cancer: Prevalence - Incidence - Mortality April 2, 2012

EAU Guidelines on Prostate Cancer April 2, 2012

Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy - Abstract April 2, 2012

Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study - Abstract April 2, 2012

Imaging diagnosis for prostate cancer biochemical recurrence after radical treatment - Abstract April 2, 2012

Treatment of the patient with castration-resistant biochemical progression of prostate cancer - Abstract April 2, 2012

Page 1305 of 1436